Findley, Amy
Middlehurst, Jessica M.
Howse, Chloe A.
Clifford, Molly J.
Neill, William
Tatlock, Sophi
Chen, Wen-Hung
Bracher, Marguerite G.
Patel, Dharm S.
Funding for this research was provided by:
GlaxoSmithKline
Article History
Received: 3 November 2022
Accepted: 13 March 2023
First Online: 20 April 2023
Declarations
:
: Ethical approval (20202526) was sought from a centralized Institutional review board (IRB) in the US (Copernicus IRB), which covered both the US and Germany aspects of this research. The project was conducted according to the principles outlined in the declaration of Helsinki and in line with guidelines related to GCP published by the FDA and EMA, where applicable to non-interventional research. All participants gave informed, written consent.
: All participants provided consent for their data from this research to be published in the public domain; however, all data included in the manuscript are anonymized so specific participants cannot be identified.
: AF, JM, CH, MC, and ST are employees of Adelphi Values, which received funding from GSK for the conduct of this study, although not for manuscript development. WN was an employee of Adelphi Values at the time of study conduct. WHC, MB and DP are employees of and/or hold stocks/shares in GSK.